Effect of Using Pictograms on Improving Depression and Anxiety Among Type 2 Diabetic Patients.

Not Applicable

Recruiting

• Conditions: Type 2 Diabetes
• Interventions: Behavioral: picograms-enriched label

• Registration Number: NCT05822349
• Lead Sponsor: University of Jordan

Brief Summary

we will study the impact of using pictograms on improving depression and anxiety among type 2 diabetic patients, we suppose that patients who received pictograms-enriched labels will have lower levels of depression and anxiety in comparison with those who will not receive after three month follow-up evaluation.

Detailed Description

Not available

Study Timeline

• Status Verified: 2023-04
• Study Start: 2023-04-01
• Study First Submitted: 2023-04-07
• Study First Submitted QC: 2023-04-07
• Last Update Submitted: 2023-04-07
• Study First Posted: 2023-04-20
• Last Update Posted: 2023-04-20
• Primary Completion: 2023-07-01
• Study Completion: 2023-08-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 204

Inclusion Criteria

• Participants are eligible if they are Jordanian adults, aged 18 or older, who have been clinically diagnosed with T2DM for at least 6 months, having low health literacy (Individuals who obtained 66 or lower scores in the full TOFHLA instrument are considered as individuals with "low literacy" in the study) [24], come personally for the refill.

Read More

Exclusion Criteria

• Patients who are unable to communicate verbally (aphasic or with hearing impairment), those with any visual, learning disabilities, and psychological or hepatorenal disease (according to the clinical diagnosis by a physician), and those deemed too ill or frail to attend the clinic, and who have participated in other diabetes education research projects will be excluded.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
intervention group	picograms-enriched label	they will receive the usual diabetes care routine plus a pictogram-enriched label.
control group	picograms-enriched label	they will receive the usual diabetes care routine.

Primary Outcome Measures

Name	Time	Method
change in depression level	12 weeks following ends of intervention	Patient Health Questionnaire-9 (PHQ-9)
change in anxiety level	12 weeks following ends of intervention	Generalized Anxiety Disorder scale (GAD-7)

Trial Locations

Locations (1)

Northern Badya Hospital; 🇯🇴 Mafraq, Jordan